How Patient Insights Improve Healthcare Decision-Making

Patients today increasingly act as contributors of evidence, not just stakeholders affected by the decisions of payers and HTA bodies. Life sciences companies can use patient experience and outcome data to inform payer decisions and ensure decision-makers consider patient voices. The challenges include the legitimacy and credibility of patient insights and the need for a strategic, systematic approach that embeds patient engagement throughout the product development process.

The Global Payer Forum 2026 focused on an urgent question: how can decision-making better reflect what matters to patients while still supporting long-term sustainability? Organized by Alira Health in partnership with leading academic institutions, the event featured a two-part webinar series. This article focuses on key takeaways from the first session, “How Patient Insights Inform Payer Decisions Across the Health System.” These takeaways point to a central conclusion: patient insights improve healthcare decision-making only when treated as decision-grade evidence, integrated early, and supported by rigorous methods, transparency, and institutional commitment.

1. Patient Insights Function as Decision-Grade Evidence

HTA bodies and payers need to recognize that patient perspectives are a legitimate form of evidence. That requires moving beyond the idea that patient input is simply a supportive testimony or human interest in addition to a technical process. Patients can help clarify which outcomes are meaningful, how disease affects daily functioning, which side effects are most disruptive, and where a therapy’s real benefit may differ from what trial endpoints suggest. Companies should generate, and payers/HTA bodies should assess this evidence with the same seriousness as other inputs, using clear methods, transparent reporting, and a deliberate connection to decision criteria.

When structured and assessed rigorously, patient insights reduce gaps between clinical evidence and real-world outcomes, improving the relevance and consistency of payer and HTA decisions.

2. Patient Engagement Starts Early and Extends Across the Lifecycle

Patient engagement should start before the reimbursement stage. Patient insights are valuable across the full continuum of decision-making: study design, endpoints, care pathway design, topic selection, HTA evaluation, reimbursement deliberation and post-implementation review. This matters because many of the problems that later appear in payer discussions and HTA assessments actually begin much earlier. Decision-makers cannot use patient-relevant evidence later if companies do not select and measure outcomes that matter to patients during development. Early engagement is not merely an idealistic aspiration; it is a practical requirement for better downstream decisions.

3. Credibility and Transparency Enable Use of Patient Experience Data

Healthcare systems will not systematically rely on patient insights unless decision-makers see the evidence as robust. That requires company leaders to think carefully about how they select participants, whether those participants reflect the diversity of the relevant patient population, and how they document and interpret findings. Both qualitative and quantitative methods have value. Qualitative research is often undervalued but is essential, but in fact, rigorous qualitative work is necessary to understand lived experience, care burdens, and the meaning of outcomes. Transparency around limitations, conflicts, and method choices gives patient evidence its practical legitimacy.

4. Patient Perspectives Expand How Value Is Defined

Patients often describe value in terms that traditional assessment frameworks do not encompass. Beyond efficacy, patients may prioritize predictability, convenience, independence, reduced caregiver burden, affordability, and the ability to maintain work, study, or family life. These dimensions do not replace clinical evidence, but they do change how payers and HTA bodies understand the overall value of a treatment. Patient perspectives can improve decisions about outcome prioritization, help identify clinically meaningful benefit thresholds, and reduce the risk that systems pay for interventions that matter less to patients.

5. System Capabilities Enable Effective Patient Engagement

Companies struggle to generate and integrate patient insights if they do not invest in the capabilities required to do so. Patient organizations need training, time, and funding to participate meaningfully in complex technical processes. HTA bodies and payers also need internal frameworks that explain how they should assess patient insights and how this information can influence their recommendations. Institutional champions are key to moving patient engagement from an ad hoc practice to a standard feature of evidence gathering and decision-making. Without that infrastructure, patient insights may remain fragmented, inconsistent, and overly dependent on individual goodwill.

Patient insights do not influence decisions by default. Their impact depends on whether health systems treat them as structured, credible evidence and integrate them consistently across decision points. Organizations that build the capabilities to generate and use patient evidence systematically will be better positioned to make more patient-centered and robust decisions.

The Global Payer Forum is an annual online event that examines key trends that reshape access to healthcare innovation. The 2026 edition featured two free, interactive webinars designed to foster cross-stakeholder collaboration, learning, practical insight sharing, and actionable guidance for decision-makers navigating this evolving landscape.

Global Payer Forum 2026 was organized by Alira Health, sponsored by Takeda, and presented in partnership with Universitat Pompeu Fabra and UCL Global Business School for Health.